BioTech
FDA approves Eli Lilly’s early Alzheimer’s treatment
Eli Lilly’s early Alzheimer’s treatment was approved by the Food and Drug Administration on Tuesday, making it the second drug on the U.S. market aimed
Elaine Chen and Matthew Herper
July 2, 2024